hungary

  1. SNT Gatchaman

    Proteomic profiling of serum small extracellular vesicles predicts post-COVID syndrome development, 2025, Dobra et al.

    Proteomic profiling of serum small extracellular vesicles predicts post-COVID syndrome development Dobra; Gyukity-Sebestyen; Bukva; Boroczky; Nyiraty; Bordacs; Varkonyi; Kocsis; Szabo; Kecskemeti; Polgar; Szell; Buzas Post-COVID syndrome affects 10–35 % of COVID-19 patients, and up to 85 % of...
  2. Wyva

    Review (Hungary) Interdisciplinary consensus statement about the diagnosis and treatment of [CFS]/myalgic encephalomyelopathy, 2025, Simonyi et al

    Interdisciplinary consensus statement about the diagnosis and treatment of chronic fatigue syndrome/myalgic encephalomyelopathy Simonyi Gábor dr ■ Bedros J. Róbert dr. ■ Réthelyi János dr. Polgár Anna dr. ■ Kiss Emese dr. Chronic fatigue syndrome/myalgic encephalomyelopathy is a disease...
  3. Wyva

    Review Long COVID – neurological or somatoform disease?, 2024, Tényi, Tényi, Janszky

    Background and purpose – Post-COVID condition (also known as long COVID) is a syndrome characterized by persistent symptoms following a suspected or confirmed SARS-CoV-2 infection, lasting for at least two months and are not attributable to other conditions. The most common symptoms include...
  4. SNT Gatchaman

    Novel biomarkers of mitochondrial dysfunction in Long COVID patients, 2024, Szögi et al.

    Novel biomarkers of mitochondrial dysfunction in Long COVID patients Szögi, Titanilla; Borsos, Barbara N.; Masic, Dejana; Radics, Bence; Bella, Zsolt; Bánfi, Andrea; Ördög, Nóra; Zsiros, Csenge; Kiricsi, Ágnes; Pankotai-Bodó, Gabriella; Kovács, Ágnes; Paróczai, Dóra; Botkáné, Andrea Lugosi...
  5. SNT Gatchaman

    Review Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches, 2024, Molnar et al.

    Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches Molnar, Tihamer; Lehoczki, Andrea; Fekete, Monika; Varnai, Reka; Zavori, Laszlo; Erdo-Bonyar, Szabina; Simon, Diana; Berki, Tímea; Csecsei, Peter; Ezer, Erzsebet The COVID-19 pandemic, caused...
  6. Wyva

    Long COVID and possible preventive options, 2023, Sebők, Gyires

    Abstract Most of the people who suffered from COVID-19 fully recovered, but approximately 10–20% of them developed a wide variety of symptoms after they recover from their initial illness. Long COVID can develop at any patient; however, several studies suggest that the development of Long Covid...
  7. Wyva

    Short and mid-term characteristics of COVID-19 disease course in athletes: A high-volume, single-center study, 2022, Juhász et al

    Abstract Introduction At the pandemic's beginning, significant concern has risen about the prevalence of myocardial involvement after SARS-CoV-2 infection. We assessed the cardiovascular burden of SARS-CoV-2 in a large cohort of athletes and identified factors that might affect the disease...
  8. Andy

    Medical educators' experiences on medically unexplained symptoms and intercultural communication—an expert focus group study, 2022, Sallay et al

    Abstract Background Medically unexplained symptoms (MUS) are highly prevalent and remain challenging in healthcare and medical education, along with the increase in the importance of intercultural issues regarding MUS. However, less is known about the challenges of professionally addressing...
  9. Wyva

    Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms, 2022, Varnai et al

    Abstract Background: Long COVID is a condition characterized by long-term sequelae persisting after the typical convalescence period of COVID-19. Previous reports have suggested the role of an unsatisfactory immune response and impaired viral clearance in the pathogenesis of long COVID...
  10. Wyva

    Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in pw Post-COVID (...), 2021, Molnar et al

    Full title: Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms Abstract Background: Post-COVID manifestation is defined as persistent symptoms or long-term complications beyond 4 weeks from disease...
  11. Andy

    Validation of the Hungarian PHQ-15. A latent variable approach, 2021, Stauder et al

    Somatic symptoms without a clear-cut organic or biomedical background, also called “medically unexplained” or “somatoform” symptoms, are frequent in primary and secondary health care. They are often accompanied by depression and/or anxiety, and cause functional impairment. The Patient Health...
  12. Kalliope

    News from the Visegrád Countries - Czech Republic, Poland, Slovakia and Hungary

    Looks like an excellent and important letter. It is signed by over 60 international ME experts.
Back
Top Bottom